Consensus CareDx, Inc

Equities

CDNA

US14167L1035

Delayed Nasdaq 15:54:51 2024-05-01 EDT 5-day change 1st Jan Change
9.2 USD +18.56% Intraday chart for CareDx, Inc +14.91% -23.58%

Evolution of the average Target Price on CareDx, Inc

Price target over the last 5 years

History of analyst recommendation changes

886b9c8f32d94aad44430d7a.d_4dQiY64G4MrikrwgwKyGKp5yy_okQ8pcPjMrDzHBE.Js1YMnwIlyhPnmRHjWhOv1L9g0nx7xZv65qCefSFQ3gzqmQ6VmuIWDn7Qg~128df1a1637df4a9155d76054c81c692
Stephens Upgrades CareDx to Overweight From Equalweight, Price Target is $10 MT
Raymond James Upgrades CareDx to Outperform From Market Perform, Price Target is $12 MT
BTIG Research Downgrades CareDx to Neutral From Buy MT
Goldman Sachs Lowers Price Target on CareDx to $13 From $25, Maintains Buy Rating MT
Stephens Downgrades CareDx to Equalweight From Overweight, Adjusts Price Target to $9 From $19 MT
Craig-Hallum Downgrades CareDx to Hold From Buy, Adjusts Price Target to $9 From $26 MT
Raymond James Downgrades CareDx to Market Perform From Strong Buy, $24 Price Target MT
Craig-Hallum Adjusts CareDx's Price Target to $26 From $32, Keeps Buy Rating MT
BTIG Adjusts Price Target on CareDx to $25 From $28, Maintains Buy Rating MT
Goldman Sachs Adjusts CareDx's Price Target to $25 From $29, Maintains Buy Rating MT
Goldman Sachs Adjusts Price Target on CareDx to $29 From $40, Maintains Buy Rating MT
Raymond James Adjusts CareDx's Price Target to $24 From $26, Maintains Strong Buy Rating MT
BTIG Adjusts Price Target on CareDx to $28 From $37, Maintains Buy Rating MT
Raymond James Adjusts Price Target on CareDx to $35 From $45, Reiterates Strong Buy Rating MT
Goldman Sachs Adjusts Price Target for CareDx to $45 From $50, Maintains Buy Rating MT
Stephens Initiates CareDx at Overweight with $50 Price Target MT
Raymond James Adjusts CareDx's Price Target to $52 from $90, Maintains Strong Buy Rating MT
Raymond James Adjusts CareDx PT to $90 From $108, Maintains Strong Buy Rating MT
CAREDX : Piper Sandler Adjusts Price Target on CareDx to $110 From $100, Reiterates Overweight Rating MT
CAREDX : BTIG Analyst Assumes Coverage on CareDx at Buy, Sets $115 Price Target MT
CAREDX : Raymond James Adjusts Price Target on CareDx to $108 From $90, Maintains Strong Buy Rating MT
CAREDX : Goldman Sachs Starts CareDx at Buy With $95 Price Target MT
CAREDX : Piper Sandler Adjusts Price Target on CareDx to $100 From $93, Maintains Overweight Rating MT
CAREDX : Raymond James Adjusts Price Target on CareDx to $90 From $98, Maintains Strong Buy Rating MT
CAREDX : Raymond James Adjusts Price Target on CareDx to $98 From $101, Maintains Strong Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
7.76 USD
Average target price
13 USD
Spread / Average Target
+67.53%
High Price Target
15 USD
Spread / Highest target
+93.30%
Low Price Target
10 USD
Spread / Lowest Target
+28.87%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CareDx, Inc

Stephens Inc.
Raymond James
BTIG
Goldman Sachs
Craig-Hallum
Piper Sandler
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings